Funded projects in the Leibniz Competition

The filter function can be used to find out about the research projects funded by the Leibniz Competition. Currently, Leibniz ScienceCampi with project start dates from 2019, Leibniz Research Alliances with project start dates from 2021 and all Leibniz Competition projects with project start dates from 2018 are included.

Ongoing projects are listed with their duration at the time of approval, i.e. without any possible extensions. Only Leibniz institutes are listed in the "Cooperation partners" column. Further cooperation partners can be found in the project description (click + on the far left).

To search for key documents of the Leibniz Association, please use this page.

Contact: saw(at)leibniz-gemeinschaft.de

[...]
Funding programme Project title Project leader Start End (planned) Cooperation partners Section Project description
Leibniz ScienceCampi Chronische Entzündung - Leibniz-WissenschaftsCampus Berlin (funding phase 2)

Prof. Dr. Andreas Radbruch 2020 DRFZ Section C - Life Sciences Arthritis, multiple sclerosis, colitis, type-2 diabetes – millions of people in Germany suffer from chronic inflammatory diseases. Those affected have constant pain of the joints, skin, nervous system or gut – any organ can be affected. Patients suffer a severe negative impact on day-to-day life. Some of these illnesses even prove to be fatal. Modern therapies have so far only managed to suppress the symptoms. In most cases, they are unable to actually cure the illness. This is precisely what the researchers at the Leibniz ScienceCampus Berlin “Centre for Chronic Inflammatory Disease” are seeking to change. To this end, doctors and scientists from various specialist fields such as rheumatology, gastroenterology, neuropathology and dermatology are working together at the Charité Hospital and the German Rheumatism Research Centre Berlin. Working across different disciplines, they research and contrast the causes and mechanisms of chronic inflammatory diseases. Their work pursues several long-term objectives. If a successful treatment already exists for a certain illness, the aim is to transfer it more rapidly to other diseases and thereby help more of those affected. Another objective is to optimally tailor therapies to individual patients and potentially even find a cure for the respective illness. Those interested can learn about this research by attending the public “LeibnizCharitéCampus Lectures”. The “LeibnizCharité-Entzündungssprechstunde” is another new offering, where doctors from different fields jointly consult with patients. External cooperation partners: Charité - Universitätsmedizin Berlin; Max-Planck-Institut für Infektionsbiologie, Berlin